505 related articles for article (PubMed ID: 16810437)
1. The in-vitro activity of colistin in gram-negative bacteria.
Tan TY; Ng SY
Singapore Med J; 2006 Jul; 47(7):621-4. PubMed ID: 16810437
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three standardized disc susceptibility testing methods for colistin.
Tan TY; Ng LS
J Antimicrob Chemother; 2006 Oct; 58(4):864-7. PubMed ID: 16905528
[TBL] [Abstract][Full Text] [Related]
3. Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli.
Somily AM
Saudi Med J; 2010 May; 31(5):507-11. PubMed ID: 20464039
[TBL] [Abstract][Full Text] [Related]
4. Colistin susceptibility testing by Etest and disk diffusion methods.
Galani I; Kontopidou F; Souli M; Rekatsina PD; Koratzanis E; Deliolanis J; Giamarellou H
Int J Antimicrob Agents; 2008 May; 31(5):434-9. PubMed ID: 18328674
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin.
Tan TY; Ng SY
Clin Microbiol Infect; 2007 May; 13(5):541-4. PubMed ID: 17371537
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
8. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit.
Ratnam I; Franklin C; Spelman DW
Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.
Sader HS; Jones RN
Int J Antimicrob Agents; 2005 Feb; 25(2):95-109. PubMed ID: 15664479
[TBL] [Abstract][Full Text] [Related]
11. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
Gales AC; Jones RN; Sader HS
J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
[TBL] [Abstract][Full Text] [Related]
12. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Ko WC; Hsueh PR
J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
[TBL] [Abstract][Full Text] [Related]
13. [Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1035-45. PubMed ID: 12899774
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis.
Ruzaimi MY; Shahril Y; Masbah O; Salasawati H
Med J Malaysia; 2006 Feb; 61 Suppl A():21-6. PubMed ID: 17042224
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2.
Tan TY; Ng LS; Poh K
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):357-61. PubMed ID: 17467946
[TBL] [Abstract][Full Text] [Related]
18. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007.
Guembe M; Cercenado E; Alcalá L; Marín M; Insa R; Bouza E
Rev Esp Quimioter; 2008 Sep; 21(3):166-73. PubMed ID: 18792817
[TBL] [Abstract][Full Text] [Related]
19. [Comparison between agar dilution and three other methods for determining the susceptibility of 228 clinical isolates of non-fermenting gram-negative rods].
Gómez-Garcés JL; Aracil B; Gil Y
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):331-7. PubMed ID: 19406523
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.
Samonis G; Matthaiou DK; Kofteridis D; Maraki S; Falagas ME
Clin Infect Dis; 2010 Jun; 50(12):1689-91. PubMed ID: 20482269
[No Abstract] [Full Text] [Related]
[Next] [New Search]